136 related articles for article (PubMed ID: 2696567)
21. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
Deloron P; Sexton JD; Bugilimfura L; Sezibera C
Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
[TBL] [Abstract][Full Text] [Related]
22. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
[No Abstract] [Full Text] [Related]
23. [In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984].
Reyes S; Osanai CH; Passos AD
Rev Bras Malariol Doencas Trop; 1986; 38():37-44. PubMed ID: 3077193
[No Abstract] [Full Text] [Related]
24. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
[TBL] [Abstract][Full Text] [Related]
25. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
[No Abstract] [Full Text] [Related]
26. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
[TBL] [Abstract][Full Text] [Related]
27. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
Hess U; Timmermans PM; Jones M
Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
[TBL] [Abstract][Full Text] [Related]
28. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
30. Quinine alone versus quinine plus a pyrimethamine-sulfadoxine combination in the treatment of Plasmodium faliciparum cerebral malaria.
Naparstek Y; Weiler-Ravell D; Shemer J; Englehard D; Sack J; Spira DT; Adler J
Am J Trop Med Hyg; 1981 Nov; 30(6):1342-3. PubMed ID: 7034564
[TBL] [Abstract][Full Text] [Related]
31. [Falciparum malaria in East African tourists in spite of fansidar prevention. A contribution on increased chloroquine and pyrimethamine-sulfadoxine resistance in areas of East Africa].
Eichenlaub D; Hoffmann HG; Rögler G; Weise HJ
Dtsch Med Wochenschr; 1983 Mar; 108(9):338-43. PubMed ID: 6337809
[TBL] [Abstract][Full Text] [Related]
32. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
De Geus A; Meuwissen JH; van Rijn A
Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
[No Abstract] [Full Text] [Related]
33. Sulfadoxine-pyrimethamine resistant malaria from west or central Africa.
Gubler J
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):433. PubMed ID: 3125942
[No Abstract] [Full Text] [Related]
34. Efficacies of chloroquine and pyrimethamine-sulphadoxine in a Nigerian population with chloroquine resistant P. falciparum malaria.
Usanga EA; Ezedinachi EN; Gemade EI; Ikpatt NW; Alaribe AA
East Afr Med J; 1990 May; 67(5):295-301. PubMed ID: 2202586
[TBL] [Abstract][Full Text] [Related]
35. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
Kilimali VA; Mkufya AR
Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine-resistant falciparum malaria from East Africa.
Bhattacharya DN; Hall AP
J Trop Med Hyg; 1986 Dec; 89(6):291-4. PubMed ID: 3543385
[TBL] [Abstract][Full Text] [Related]
37. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
38. A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.
Ebisawa I; Ohara H
Jpn J Exp Med; 1986 Oct; 56(5):213-9. PubMed ID: 3543442
[TBL] [Abstract][Full Text] [Related]
39. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):10-3. PubMed ID: 7036765
[TBL] [Abstract][Full Text] [Related]
40. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
